Hearing Resources and Outcomes in the Emergency Department (HERO-ED)



Status:Withdrawn
Conditions:Other Indications, Hospital
Therapuetic Areas:Other
Healthy:No
Age Range:75 - Any
Updated:1/7/2018
Start Date:February 3, 2017
End Date:January 3, 2018

Use our guide to learn which trials are right for you!

The Hearing Resources and Outcomes in the Emergency Department Pilot (HERO-ED Pilot), gathers
preliminary data and hones procedures and measures, prior to undertaking HERO-ED. Since the
HERO-ED Pilot does not involve random assignment (no control group), it will not test device
effectiveness. However, the HERO-ED Pilot will test device acceptability and use. It will
also provide preliminary data on, and allow us to fine-tune, the measures of effectiveness
that we plan to use in HERO-ED

The objectives are:

1. Measure the feasibility of in-ED hearing screening using HHIE-S and a handheld
audiometer, among low-acuity11 ED patients age ≥75 years, by quantifying the proportion
of eligible patients who complete hearing screening.

2. Test whether low-acuity older ED patients who screen positive for significant hearing
loss (> 40 dB HL bilaterally and HHIE-S > 24) and are provided a hearing assistance
device (HAD) use that device during the ED visit.

3. Test whether patients who are given a hearing assistance device will report ability as
opposed to disability in hearing and understanding, using a six-item questionnaire
adapted from a study by Cox et al.

4. Test whether those who are given a hearing assistance device will report being prepared
for post-discharge care, using an adapted subset of the Care Transitions Measures (CTM).

5. Assess patient understanding of the HAD survey items within the post-use survey.

Inclusion Criteria:

- low acuity clinical presentation (Emergency Severity Index11 triage criteria of 4 or
5, which indicates a high likelihood of being discharged home from the Emergency
Department).

- Patients using hearing aids will not be excluded.

Exclusion Criteria:

- Lack of capacity to consent, as defined by the patient's ability to satisfactorily
answer the questions outlined in the Evaluation to Sign Consent form (ESC) mentioned
in the protocol. A legal representative/family member will not be able to consent for
the patient in this study.
We found this trial at
1
site
New York, New York 10021
Principal Investigator: Joshua Chodosh, MD
?
mi
from
New York, NY
Click here to add this to my saved trials